Are DOACs Actually Safer in Advanced Cirrhosis – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Daniel Tham et al, adding:
“Are DOACs actually safer in advanced cirrhosis?
For years, anticoagulation in Child-Pugh B/C cirrhosis has lived in the “too risky / not enough data” zone. This new meta-analysis pushes that conversation forward in a big way.
Across 16 studies and >17,000 patients, DOACs were compared with warfarin/LMWH in cirrhosis.
Here’s what stood out
Major bleeding was LOWER with DOACs
- CP B/C subgroup: OR 0.53
- Overall cohort: OR 0.60
- No increase in VTE recurrence or stroke risk
- Minor bleeding also trended lower overall
Translation: DOACs may not just be convenient; they may actually be safer than traditional anticoagulation in cirrhosis.
But here’s the nuance:
Most data remain observational, and evidence in Child-Pugh C is still limited. We’re seeing strong signals, not the final word.
This is exactly the type of evidence clinicians have been waiting for to guide real-world decision-making in a notoriously difficult population.”
Title: Safety and efficacy of direct oral anticoagulants in patients with liver cirrhosis: a meta-analysis
Authors: Daniel Tham, Wenhui Yu, Lucy Zhao, Roger Kou, Jayhan Kherani, Pei Yi Li, Shreyas Sreeraman, Ali Eshaghpour, Allen Li, Mark A. Crowther
Read the Full Article on RPTH Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 2, 2026, 04:47Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
-
Apr 2, 2026, 04:28Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
-
Apr 2, 2026, 04:18Emmanuele Kouvousis: Physical Inactivity as a Leading Global Health Risk
-
Apr 2, 2026, 04:03Robert Lufkin: The Misleading Concept of Metabolically Healthy Obesity in Childhood
-
Apr 1, 2026, 23:00Wolfgang Miesbach: What Goes Wrong When Approved Gene Therapies Get Withdrawn?
-
Apr 1, 2026, 22:00Aurelio Maggio: Congratulations to Mariasanta Napolitano on Her 1st Year Leading the Haematology and Rare Disease Uni tat ”V. Cervello” Hospital
-
Apr 1, 2026, 21:21Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
-
Apr 1, 2026, 21:00Johns Hopkins All Children’s Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence – NBCA
-
Apr 1, 2026, 20:17Aswin K Mohan: The Most Common Misconceptions on Blood Donation